# Old myocardial infarction

- Category: acute
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: Egyptian National Drug Formulary - cardiovascular.pdf, Atorvastatin monograph (chapter PDF p207) · Ojha N, Dhamoon AS. Myocardial Infarction. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Updated 2023 Aug 8. Bookshelf ID: NBK537076.
- Verified date: 2026-08

## Verified against

- Egyptian National Drug Formulary - cardiovascular.pdf, Atorvastatin monograph (chapter PDF p207)

## Treatment metadata

- Atorvastatin — oral.solid

## Complete treatment card

```text
OLD MYOCARDIAL INFARCTION
Sources: Egyptian National Drug Formulary - cardiovascular.pdf, Atorvastatin monograph (chapter PDF
         p207) · Ojha N, Dhamoon AS. Myocardial Infarction. In: StatPearls [Internet]. Treasure
         Island (FL): StatPearls Publishing; 2026 Jan-. Updated 2023 Aug 8. Bookshelf ID: NBK537076.
Review status: REVIEWED against the source listed above  (2026-08)

1. ATORVASTATIN                                           [1st line]
   Adult    80 mg once daily (secondary-prevention statin dose after myocardial infarction). - Long-
            term / indefinite.
   Peds     Not applicable - this is an adult condition; paediatric statin dosing (from age 10, for
            familial hypercholesterolaemia only) is specialist-set and is not reproduced here.
   Source   Egyptian National Drug Formulary - cardiovascular.pdf, Atorvastatin monograph (chapter
            PDF p207)
   Why      High-intensity statin therapy is standard lifelong secondary prevention after a
            myocardial infarction, regardless of baseline cholesterol level.
   Caution  Recurrent chest pain, new breathlessness or oedema suggesting heart failure,
            palpitations suggesting arrhythmia.
            Check liver function and creatine kinase before starting and if muscle symptoms develop.
            Watch for myopathy, especially with interacting drugs (e.g. clarithromycin, fibrates).
            Counsel on the need for lifelong adherence even though the patient feels well.
            Contraindicated in acute liver failure or decompensated cirrhosis, and during pregnancy
            or lactation.
   Egypt    PREVENVAST 10 MG 10 TAB.         CID                  6.50 EGP (0.65/unit)
            ANTICHOL 10 MG 10 F.C. TAB.      JEDCO INT. CO...     8.50 EGP (0.85/unit)
            LIPOVAST 10MG 7 F.C.TAB.         MISR                 9.25 EGP (1.32/unit)
            LIRIMAR 80 MG 10 CAPS.           RIVA PHARMA S...    29.00 EGP (2.90/unit)
            LIPINORM 10 MG 7 F.C.TAB.        MUP                 28.00 EGP (4.00/unit)
            ATOR 40 MG 10 F.C.TABS.          EIPICO             106.00 EGP (10.60/unit)
            HIPOLIXAVAST 10 MG 30 CHEW. TABS. EGPI                                        114.00 EGP
            HIPOLIXAVAST 20 MG 30 CHEW. TABS. EGPI                                        127.50 EGP

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)